Technical Analysis for AKAO - Achaogen, Inc.

Grade Last Price % Change Price Change
grade F 0.55 -2.36% -0.01
AKAO closed down 2.36 percent on Monday, March 18, 2019, on 1.25 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Mar 28

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AKAO trend table...

Date Alert Name Type % Chg
Mar 18 MACD Bullish Signal Line Cross Bullish 0.00%
Mar 18 NR7 Range Contraction 0.00%
Mar 18 NR7-2 Range Contraction 0.00%
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Oversold Stochastic Weakness 0.00%
Mar 15 NR7 Range Contraction -2.36%
Mar 15 Inside Day Range Contraction -2.36%
Mar 15 Wide Bands Range Expansion -2.36%
Mar 15 Oversold Stochastic Weakness -2.36%
Mar 14 New 52 Week Closing Low Bearish 7.78%

Older signals for AKAO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Achaogen, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant gram-negative infections. The company is principally developing plazomicin, which has completed Phase II clinical trials for the treatment of bacterial infections due to multi-drug resistant Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. It is also involved in the research and development of antipseudomonal programs that target infections caused by Pseudomonas aeruginosa. Achaogen, Inc. was incorporated in 2002 and is headquartered in South San Francisco, California.
Biopharmaceutical Infectious Diseases Infections Bacterial Infections Antibiotic Bacteria Multiple Drug Resistance Carbapenem Pseudomonas Gram Negative Bacteria Microorganisms Pseudomonas Aeruginosa Multi Drug Resistant Gram Negative Infections
Is AKAO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.0
52 Week Low 0.51
Average Volume 1,745,171
200-Day Moving Average 4.3142
50-Day Moving Average 1.1409
20-Day Moving Average 0.7152
10-Day Moving Average 0.6281
Average True Range 0.0939
ADX 33.49
+DI 10.5611
-DI 32.3525
Chandelier Exit (Long, 3 ATRs ) 1.3483
Chandelier Exit (Short, 3 ATRs ) 0.7917
Upper Bollinger Band 0.9339
Lower Bollinger Band 0.4965
Percent B (%b) 0.12
BandWidth 61.157718
MACD Line -0.1787
MACD Signal Line -0.1803
MACD Histogram 0.0016
Fundamentals Value
Market Cap 23.23 Million
Num Shares 42.2 Million
EPS -3.10
Price-to-Earnings (P/E) Ratio -0.18
Price-to-Sales 14.82
Price-to-Book 2.95
PEG Ratio -0.07
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.63
Resistance 3 (R3) 0.63 0.60 0.61
Resistance 2 (R2) 0.60 0.58 0.60 0.61
Resistance 1 (R1) 0.58 0.57 0.57 0.58 0.60
Pivot Point 0.55 0.55 0.55 0.55 0.55
Support 1 (S1) 0.53 0.53 0.52 0.53 0.50
Support 2 (S2) 0.50 0.52 0.50 0.49
Support 3 (S3) 0.48 0.50 0.49
Support 4 (S4) 0.48